Personal CFO Solutions’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Personal CFO Solutions’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.09M	Buy	32,316 +833	+3%	+$27.7K	0.16%	115
2026 Q1	$948K	Buy	31,483 +22,441	+248%	+$722K	0.13%	135
2025 Q4	$282K	Buy	+9,042	New	+$223K	0.04%	389
2025 Q2	–	Sell	-10,259	Closed	-$158K	–	509
2025 Q1	$158K	Sell	10,259 -33	-0.3%	-$589	0.03%	440
2024 Q4	$227K	Sell	10,292 -188	-2%	-$3.42K	0.04%	408
2024 Q3	$189K	Buy	+10,480	New	+$183K	0.03%	546

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Personal CFO Solutions's TEVA Position: Q2 2026 in Review

Personal CFO Solutions increased its Teva Pharmaceutical Industries Limited (TEVA) stake by 2.6% in Q2 2026, buying an estimated $27.7K and bringing the position to 32,316 shares worth $1.09M. The position accounts for 0.16% of the portfolio, ranked #115.

Personal CFO Solutions first reported a position in TEVA in Q3 2024 and has held it in 6 quarters since. 677 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Personal CFO Solutions held 32,316 shares of Teva Pharmaceutical Industries Limited worth $1.09M as of Q2 2026.
Personal CFO Solutions bought 833 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $27.7K.
Teva Pharmaceutical Industries Limited made up 0.16% of Personal CFO Solutions's portfolio in Q2 2026, its #115 holding.
Personal CFO Solutions first reported a position in Teva Pharmaceutical Industries Limited in Q3 2024 and has held it in 6 quarters since.
677 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Personal CFO Solutions's 13F filing for Q2 2026, filed 7 Aug 2026.